Pioneering new therapy for prostate cancer

Scientists at Imperial Collegeare testing a new therapy to stop prostate cancer advancing to a deadly stage.

The team is developing "designer" proteins that could help patients once other methods have failed.

Each year around 37,000 men in the UK develop prostate cancer and 11,000 will die from the disease.